Subject Specializations
Dr. Stark reviews and testifies across six recurring areas in oncology malpractice and product liability litigation — from failure-to-diagnose claims in the three most common adult cancers, to chemotherapy toxicity, screening standards, and the proper use of tumor doubling time in causation. Each summary below links to a deeper discussion of the issues that drive litigation in that area.
- 01
Breast Cancer Issues
The most common reasons for breast cancer lawsuits are failure to interpret a mammogram properly and failure to evaluate a woman's complaint of a lump in her breast.
Read about breast cancer issues - 02
Colon Cancer Issues
Colon cancer is among the slowest-growing common adult tumors, with characteristics that make a missed diagnosis an ideal case for a plaintiff.
Read about colon cancer issues - 03
Lung Cancer Issues
The overall mortality of lung cancer is 90%. By the time a patient complains of coughing up blood or chest pain, it is almost always too late to effect a cure.
Read about lung cancer issues - 04
Chemotherapy Complications
Not every bad result associated with cancer chemotherapy is caused by negligent care. Mediports and similar devices have a simple structure, but one that can fail without warning.
Read about chemotherapy complications - 05
Cancer Screening
From a litigation perspective, it has been clear since 2011 that failure to offer colorectal or breast cancer screening is negligent. The same cannot be said for much rarer syndromes.
Read about cancer screening
Discuss a case or evidence review.
Reach out directly by phone or email — no intake forms, no gatekeeping.